Characteristic | MRS 0-2 (n = 426) | MRS 3-6 (n = 159) | P |
---|---|---|---|
Male/Female | 283/143 | 107/52 | 0.844 |
Age, y | 39.6 ± 6.5 | 39.2 ± 6.5 | 0.504 |
Current cigarette smoking, n (%) | 120 (28.2%) | 48 (30.2%) | 0.631 |
Current Alcohol drinking, n (%) | 78 (18.3%) | 30 (18.9%) | 0.877 |
Previous stroke/TIA, n (%) | 56 (13.1%) | 9 (5.7%) | 0.010 |
Atrial fibrillation, n (%) | 14 (3.3%) | 24 (15.1%) | 0.000 |
Hypertention, n (%) | 190 (44.6%) | 76 (47.8%) | 0.49 |
Diabetes at baseline, n (%) | 70 (16.4%) | 43 (27.0%) | 0.004 |
Hypercholesterolemia, n (%) | 137 (32.2%) | 41 (257%) | 0.136 |
Hypertriglyceridemia, n (%) | 161 (37.8%) | 43 (27.0%) | 0.015 |
Metabolic syndrome presence, n (%) | 21 (4.9%) | 10 (6.3%) | 0.003 |
Family history of stroke, n (%) | 19 (4.5%) | 13 (8.2%) | 0.079 |
Moyamoya/Cerebral vascular malformation, n (%) | 14 (3.3%) | 13 (8.2%) | 0.012 |
TOAST classification | Â | Â | 0.000 |
a. Large artery, n (%) | 127 (29.8%) | 84 (52.8%) | Â |
b. Small artery, n (%) | 226 (53.1%) | 19 (12.0%) | Â |
c. Cardioembolism, n (%) | 21 (4.9%) | 31 (19.5%) | Â |
d. Other cause, n (%) | 52 (12.2%) | 25 (15.7%) | Â |
nonfasting glucose, mmol/L | 5.65 ± 2.44 | 6.44 ± 3.03 | 0.001 |
Platelet distribution width, fL | 12.7 ± 4.6 | 12.1 ± 3.0 | 0.072 |
Platelet count, ×109/L | 237.8 ± 80.0 | 224.9 ± 82.9 | 0.019 |
White cell count, ×109/L | 8.6 ± 5.6 | 10.0 ± 4.2 | 0.000 |
Mean platelet volume, fl | 10.2 ± 1.4 | 10.2 ± 1.5 | 0.85 |
UA, mmol/L | 326.2 ± 103.4 | 295.7 ± 111.2 | 0.002 |
Triglyceride (TG), mmol/L | 1.7 ± 1.4 | 1.6 ± 1.6 | 0.382 |
Cholesterol (CHOL), mmol/L | 4.7 ± 1.1 | 4.9 ± 1.1 | 0.017 |
Fibrinogen, g/l | 1.7 ± 0.4 | 2.7 ± 1.7 | 0.000 |